Potent gene regulatory and antiproliferative activities of 20-methyl analogues of 1,25 dihydroxyvitamin D3

Journal of Cellular Biochemistry

Volumn 63, Issue 2, 1996, Pages 199-206

  Danielsson, Carina ^a   Nayeri, Sepideh ^a   Wiesinger, Herbert ^b   Thieroff Ekerdt, Ruth ^b   Carlberg, Carsten ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b BAYER PHARMA AG   (Germany)

Author keywords

breast cancer cells; control of proliferation; limited protease digestion assay; lymphocytes; promoter selectivity; regulation of transcription; vitamin D3 analogues; vitamin D3 receptor

Indexed keywords

COLECALCIFEROL DERIVATIVE;

ARTICLE; BREAST CANCER; CALCIUM HOMEOSTASIS; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG CONFORMATION; DRUG EFFECT; DRUG POTENCY; DRUG RECEPTOR BINDING; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR AFFINITY; REGULATOR GENE; TRANSCRIPTION REGULATION;

BREAST NEOPLASMS; CALCITRIOL; CELL DIFFERENTIATION; CELL DIVISION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LYMPHOCYTES; RECEPTORS, CALCITRIOL; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0029903375     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19961101)63:2<199::AID-JCB7>3.0.CO;2-T     Document Type: Article

References (30)

1. Bikle DD, Pillai S (1993): Vitamin D, calcium, and epidermal differentiation. Endocr Rev 14:3-19.
2. 3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochem Pharmacol 42:1569-1575.
3. Bouillon R, Allewaert K, Xiang DZ, Tan BK, van Baelen H (1991): Vitamin D analogs with low affinity for the vitamin D binding protein: enhanced in vitro and decreased in vivo activity. J Bone Mineral Res 6:1051-1057.
4. Bouillon R, Okamura WH, Norman AW (1995): Structure-function relationships in the vitamin D endocrine system. Endocr Rev 16:200-257.
5. 3: interplay with retinoid and thyroid hormone signalling. Eur J Biochem 231:517-527.
6. Carlberg C, Bendik I, Wyss A, Meier E, Sturzenbecker LJ, Grippo JF, Hunziker W (1993): Two nuclear signalling pathways for vitamin D. Nature 361:657-660.
7. 3 analogues MC903, EB1089 and KH1060 function as transcriptional activators: vitamin D receptor homodimers show higher ligand sensitivity than heterodimers with retinoid X receptors. J Steroid Biochem Molec Biol 51:137-142.
8. 3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. Cancer Res 55:2822-2830.
9. Fanjul A, Dawson MI, Hobbs PD, Jong L, Cameron JF, Harlev E, Graupner G, Lu X-P, Pfahl M (1994): A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature 372:107-111.
10. 3 metabolites. Cancer Res 43:4443-4447.
11. James SY, Mackay AG, Colston KW (1995): Vitamin D derivatives in combination with 9-cis retinoic acid promote active cell death in breast cancer cells. J Mol Endocrinol 14:391-394.
12. Jiang H, Lin J, Su Z-z, Collart FR, Huberman E, Fisher PB (1994): Induction of differentiation in human promyelotic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9:3397-3406.
13. 3 induced differentiation in a human promyelocytic leukemia cell line HL-60: receptor-mediated maturation to macrophage-like cells. J Cell Biol 98:391-398.
14. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM (1995): The nuclear receptor superfamily: the second decade. Cell 83:835-839.
15. Mathiasen IS, Colston KW, Binderup L (1993): EB1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells. J Steroid Biochem Molec Biol 46:365-371.
16. 3 in human breast cancer MCF-7 cells is related to promoter selectivity. Int J Cancer: in press.
17. Mørk Hansen C, Mathiasen IS, Binderup L (1996b): The antiproliferative and differentiation-inducing effects of vitamin D analogues are not determined by the binding affinity for the vitamin D receptor alone. J Invest Dermatol 106: S44-S48.
18. 3 analogues is not related to the AP-1 pathway, but related to promoter selectivity. Oncogene 11:1853-1858.
19. 3 correlates well with gene activation. J Cell Biochem 61: in press.
20. Neef G, Kirsch G, Schwarz K, Wiesinger H, Menrad A, Fähnrich M, Thieroff-Ekerdt R, Steinmeyer A (1995): 20-methyl vitamin D analogues. Proceedings of the 9th workshop on vitamin D. Norman AW, Bouillon R, Thomasset M (eds) de Gruyter, Berlin: 97-98.
21. 3 are associated with enhanced activation of the vitamin D receptor. J Biol Chem 270:10551-10558.
22. 3 receptors: structure and function in transcription. Annu Rev Nutr 11:189-216.
23. Pothier F, Quellet M, Julien J-P, Guérin SL (1992): An improved CAT assay for promoter analysis in either transgenic mice or tissue culture cells. DNA Cell Biol 11:83-90.
24. Schräder M, Müller KM, Becker-André M, Carlberg C (1994a): Response element selectivity for heterodimerization of vitamin D receptors with retinoic acid and retinoid X receptors. J Mol Endocrinol 12:327-339.
25. 3R heterodimer polarity directs ligand sensitivity of transactivation. Nature 370:382-386.
26. 3 response elements formed by inverted palindromes: polarity-directed ligand sensitivity of VDR-RXR heterodimer-mediated transactivation. Mol Cell Biol 15:1154-1161.
27. Vieth R (1990): The mechanisms of vitamin D toxicity. Bone Mineral 11:267-272.
28. Walters MR (1992): Newly identified actions of the vitamin D endocrine system. Endocr Rev 13:719-764.
29. Wiberg K, Ljunghall S, Binderup L, Ljunggren O (1995): Studies on two new vitamin D analogs, EB1089 and KH1060: effects on bone resorption and osteoclast recruitment in vitro. Bone 17:391-395.
30. Zhang Q, Wrana JL, Sodek J (1992): Characterization of the promoter region of the porcine opn (osteopontin, secreted phosphoprotein 1) gene. Eur J Biochem 207:649-659.